Evidence of clinical benefit of WHO essential anticancer medicines for children, 2011–2021

BACKGROUND: Access to essential cancer medicines is a key determinant of childhood cancer survival. WHO published the Model List of Essential Medicine for Children (EMLc) and updated it every two years since 2007 to promote better access to medicines for children. This study aimed to assess whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Lin, Zhan, Yuqi, Zhou, Yue, Zhang, Yichen, Shi, Luwen, Gupta, Sumit, Denburg, Avram, Guan, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130597/
https://www.ncbi.nlm.nih.gov/pubmed/37125406
http://dx.doi.org/10.1016/j.eclinm.2023.101966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130597/
https://www.ncbi.nlm.nih.gov/pubmed/37125406
http://dx.doi.org/10.1016/j.eclinm.2023.101966

Ejemplares similares